Ardent Health (ARDT) is drawing fresh attention after announcing a partnership with hellocare.ai to roll out an AI assisted virtual care platform across more than 2,000 patient rooms, focused on monitoring and patient safety.

The AI partnership sits against a mixed trading backdrop, with a 14.1% 1 month share price return and a 9.7% year to date share price return, while 1 year total shareholder return is a 37.5% decline as legal and accounting concerns remain in focus.

If this AI healthcare push has your attention, it could be worth widening your search to other opportunities in the sector through our screener of 29 healthcare AI stocks.

With Ardent trading at US$9.48 against an average analyst price target of US$13.07, and legal questions still hanging over the story, you have to ask: is there real value here, or is the market already pricing in future growth?

Most Popular Narrative: 27.4% Undervalued

Ardent Health's most followed narrative places fair value at $13.07 per share versus the last close at $9.48, and that gap rests on some specific operating shifts.

The accelerated deployment of advanced technology, including AI-enabled scribe tools, virtual nursing, and digital wearables, improves clinical efficiency, reduces labor costs, limits nurse turnover, and streamlines workflow, all of which bolster operational efficiency and EBITDA margins.

Read the complete narrative. Read the complete narrative.

Curious what kind of revenue trajectory and margin profile need to line up for that valuation to make sense? The narrative leans on steady top line expansion, firmer profitability, and a future earnings multiple that stays below many large US healthcare names. Want to see how those moving parts fit together in the fair value math?

Result: Fair Value of $13.07 (UNDERVALUED)

However, that story can quickly change if professional fees, payer denials, or any fallout from the securities lawsuit affect earnings quality more than expected.

Another Angle: DCF Says Overvalued

There is a twist when you look at Ardent through the SWS DCF model. On this view, the shares trade at $9.48 versus an estimated future cash flow value of $4.87, which screens as overvalued. So which matters more for you: earnings power or cash flow assumptions?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Ardent Health for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 54 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If this mix of AI potential and valuation debate leaves you on the fence, take a moment to review the data yourself. Then move quickly to shape your own view with 5 key rewards.

Ready to hunt for your next idea?

If Ardent has raised good questions for you, do not stop here. Your next strong opportunity could be waiting in just a few focused screener results.

• Target potential mispricing by scanning our list of 54 high quality undervalued stocks that may offer more attractive entry points.
• Prioritise resilience with 80 resilient stocks with low risk scores, built for investors who want steadier business profiles and fewer negative surprises.
• Spot earlier stage potential through the screener containing 24 high quality undiscovered gems that have solid fundamentals but limited market attention so far.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.